Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rb-82 Infusion Profiles in Myocardial Perfusion PET
NCT05286593Phase 4Completed
- Sponsor
- Ochsner Clinic Foundation
- Start
- Dec 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rubidium-82 chloride in coronary artery disease (CAD), sponsored by Ochsner Clinic Foundation. Started Dec 2021; status: completed.
02
Drugs
rubidium-82 chloride
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT05286593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05286593.